Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations
Conditions: Uterine Neoplasms; Uterine Cervical Neoplasms; Biliary Tract Neoplasms; Urologic Neoplasms; Carcinoma, Non-Small-Cell Lung; Breast Neoplasms Interventions: Drug: tucatinib; Drug: trastuzumab; Drug: fulvestrant Sponsor: Seattle Genetics, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer & Oncology | Carcinoma | Genetics | HER2 | Herceptin | Research | Study | Urology & Nephrology